EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Burden and Risk Factors of CGM ‐Detected Hypoglycemia in Older Adults With Type 2 Diabetes

Michael Fang, Natalie Rula Daya iD, Yein Jeon, Justin B Echouffo-Tcheugui, B Gwen Windham, Scott Zeger, Elizabeth Selvin

Journal of the American Geriatrics Society · 2026

DOI: 10.1111/jgs.70412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, 2026. Verfasst von Michael Fang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemia, Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIA NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Comprehensive data on the burden of biochemical hypoglycemia in older adults with type 2 diabetes are lacking. We seek to characterize the burden and risk factors for hypoglycemia detected by continuous glucose monitoring (CGM) in older adults with type 2 diabetes.

Methods

A cross‐sectional analysis of 315 older adults with type 2 diabetes who attended visit 9 of the Atherosclerosis Risk in Communities Study (2021–2022). We examined rates of Level 1 hypoglycemia (< 70 mg/dL) and percentage meeting recommended targets for hypoglycemia (< 1% of time). We identified risk factors for CGM‐detected hypoglycemia by comparing the median time spent in hypoglycemia across subgroups. All analyses were stratified by high‐risk medication use (insulin/sulfonylureas vs. not).

Results

Of the 315 participants with type 2 diabetes (mean age 83 years, 55% women, 41% Black adults), 32.4% were using insulin or sulfonylureas. Among individuals using these high‐risk medications, the median time spent in hypoglycemia was 3.4%, and ~66% of participants spent more than 1% of the time with CGM glucose < 70 mg/dL. Hypoglycemic episodes typically occurred overnight and lasted a median of ~1.5 h among individuals using insulin or sulfonylureas. CGM‐detected hypoglycemia was low in participants not using high‐risk medications (median time spent in hypoglycemia: 0.7%). In unadjusted analyses, cardiovascular disease, cognitive impairment, poor physical functioning, and chronic kidney disease were associated with increased time spent in hypoglycemia, regardless of high‐risk medication use.

Conclusions

There may be a substantial burden of unrecognized CGM‐detected hypoglycemia in very old adults with type 2 diabetes using high‐risk medications in the general population. Hypoglycemia may also be present among persons not on high‐risk medication, but the burden is much lower. Further research is needed to clarify the clinical significance of these hypoglycemic episodes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2HypoglycemiaHypoglycemic AgentsHumansContinuous Glucose MonitoringFemaleRisk FactorsCross-Sectional StudiesAged, 80 and overMaleAgedSulfonylurea CompoundsInsulinBlood GlucoseInsulin Secretagogues

Stichwörter der Autor:innen

continuous glucose monitoringcorrelates/correlationdiabetes in elderlyglucose monitoring technologieshypoglycemia

Substanzen

Hypoglycemic AgentsSulfonylurea CompoundsInsulinBlood GlucoseInsulin Secretagogues

Autor:innen und Institutionen

  • Department of Epidemiology and the Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Department of Biomedical and Health Informatics, University of Washington, Seattle, Washington, USA.
  • Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Medicine, MIND Center, University of Mississippi Medical Center, Jackson, Mississippi, USA.
  • Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

ORCID-Profile: Natalie Rula Daya

Förderung

  • NHLBI NIH HHS
  • NIA NIH HHS
  • NIDDK NIH HHS
  • National Institute on Aging
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Fang, M., Daya, N. R., Jeon, Y., Echouffo-Tcheugui, J. B., Windham, B. G., Zeger, S., & Selvin, E. (2026). Burden and Risk Factors of CGM ‐Detected Hypoglycemia in Older Adults With Type 2 Diabetes. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.70412

Vancouver

Fang M, Daya NR, Jeon Y, Echouffo-Tcheugui JB, Windham BG, Zeger S, et al. Burden and Risk Factors of CGM ‐Detected Hypoglycemia in Older Adults With Type 2 Diabetes. Journal of the American Geriatrics Society. 2026. doi:10.1111/jgs.70412

BibTeX
@article{Fang2026,
  author = {Fang, Michael and Daya, Natalie Rula and Jeon, Yein and Echouffo-Tcheugui, Justin B and Windham, B Gwen and Zeger, Scott and Selvin, Elizabeth},
  title = {Burden and Risk Factors of CGM ‐Detected Hypoglycemia in Older Adults With Type 2 Diabetes},
  journal = {Journal of the American Geriatrics Society},
  year = {2026},
  doi = {10.1111/jgs.70412}
}
Kostenlos starten →